Functional analysis of a novel inhibitory receptor expressed on plasmacytoid dendritic cells
浆细胞样树突状细胞表达的新型抑制性受体的功能分析
基本信息
- 批准号:15590432
- 负责人:
- 金额:$ 2.3万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2003
- 资助国家:日本
- 起止时间:2003 至 2004
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Inhibitory receptors play crucial roles for fine regulation and termination of immune responses by negatively regulating cellular functions. A number of inhibitory receptors have been identified on various types of cells. In particular, inhibitory receptors on natural killer cells have been well characterized. It has been postulated that recognition of MHC class I, or related molecules, on target cells by inhibitory NK receptors allows NK cells to prevent self killing but destroy inappropriate cells possessing decreased levels of MHC class I.Ly49Q is an ITIM-bearing inhibitory receptor belonging to Ly49 family that is known as one of subfamilies of NK receptors. Even though Ly49Q is classified into Ly49 family because of highly structural similarities and of its chromosomal location, Ly49Q has unique features different from other Ly49 family members. Ly49Q is not expressed on NK and NKT cells, but predominantly expressed on macrophages and plasmacytodi dendritic cells. Ly49Q has an abi … More lity to associate with both SHP-1 and SHP-2 in a tyrosine phosphorylation-dependent manner.We here demonstrate that different expression levels of Ly49Q defined sequential maturational stages of PDCs in bone marrow. Moreover, we identified functionally different subsets of PDCs according to the expression of Ly49Q. Most CD11c^+B220^+PDCs in spleen and lymph node expressed high levels of Ly49Q. However, a significant portion of PDCs in BM, blood, liver and lung lacked Ly49Q expression. Ly49Q^- PDCs possessed lower abilities to produced IFN-αβ/, IL-6 and IL-12 p70 than Ly49Q^+ PDCs in response to TLR ligands. Interestingly, however, Ly49Q^- PDCs bore an ability to produce equivalent levels of TNF-α to Ly49Q^+ PDCs when exposed to CpG and HVJ. Thus, Ly49Q is a useful marker to reveal maturation process of PDCs and to distinguish functionally different subsets of PDCs. Our results suggest that cytokine profiles of PDCs alter during their maturational processes and that PDCs play different immunological functions depending on their maturational stages. To understand functional relevance of Ly49Q as well as MHC class I recognition by macrophages and dendritic cells, we started to establish transgenic mice expressing Ly49Q. Less
抑制性受体通过负性调节细胞功能,在精细调节和终止免疫应答中发挥关键作用。已经在各种类型的细胞上鉴定了许多抑制性受体。特别是,自然杀伤细胞上的抑制性受体已经得到很好的表征。据推测,通过抑制性NK受体识别靶细胞上的MHC I类或相关分子,允许NK细胞防止自我杀伤,但破坏具有降低水平的MHC I类的不适当的细胞。Ly 49 Q是一种携带ITIM的抑制性受体,属于Ly 49家族,该家族被称为NK受体的亚家族之一。尽管Ly 49 Q由于其高度的结构相似性和染色体位置而被归类为Ly 49家族,但Ly 49 Q具有不同于其他Ly 49家族成员的独特特征。Ly 49 Q在NK和NKT细胞上不表达,但主要在巨噬细胞和浆细胞树突状细胞上表达。ly 49 q有一个abi ...更多信息 Ly 49 Q与SHP-1和SHP-2均以酪氨酸磷酸化依赖的方式结合,我们在此证明Ly 49 Q的不同表达水平决定了骨髓PDCs的连续成熟阶段。此外,我们根据Ly 49 Q的表达鉴定了功能不同的PDCs亚群。脾和淋巴结中大多数CD 11 c ^+B220^+PDCs表达高水平的Ly 49 Q。然而,BM、血液、肝脏和肺中的显著部分的PDC缺乏Ly 49 Q表达。与Ly 49 Q ^+ PDCs相比,Ly 49 Q ^-PDCs对TLR配体产生IFN-αβ/、IL-6和IL-12 p70的能力较低。然而,有趣的是,当暴露于CpG和HVJ时,Ly 49 Q ^- PDCs具有产生与Ly 49 Q ^+ PDCs相同水平的TNF-α的能力。因此,Ly 49 Q是一个有用的标志物,以揭示PDCs的成熟过程和区分功能不同的PDCs的子集。我们的研究结果表明,PDCs的细胞因子谱在其成熟过程中发生变化,PDCs发挥不同的免疫功能,这取决于其成熟阶段。为了了解Ly 49 Q的功能相关性以及巨噬细胞和树突状细胞对MHC I类的识别,我们开始建立表达Ly 49 Q的转基因小鼠。少
项目成果
期刊论文数量(32)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Noriko Toyama-Sorimachi, et al.: "Ly49Q, a member of the Ly49 family that is selectively expressed on myeloid lineage cells and involved in regulation of cytoskeletal architecture."Proc.Nati.Acad.Sci.USA. 101. 1016-1021 (2004)
Noriko Toyama-Sorimachi 等人:“Ly49Q 是 Ly49 家族的成员,在骨髓谱系细胞上选择性表达并参与细胞骨架结构的调节。”Proc.Nati.Acad.Sci.USA。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Dok-1 and Dok-2 are negative regulators of lipopolysaccharide-induced signaling.
DOK-1和DOK-2是脂多糖诱导的信号传导的负调节剂。
- DOI:10.1084/jem.20041817
- 发表时间:2005-02-07
- 期刊:
- 影响因子:0
- 作者:Shinohara H;Inoue A;Toyama-Sorimachi N;Nagai Y;Yasuda T;Suzuki H;Horai R;Iwakura Y;Yamamoto T;Karasuyama H;Miyake K;Yamanashi Y
- 通讯作者:Yamanashi Y
Inhibitory NK receptor Ly49Q is expressed on subsets of dendritic cells in a cellular maturation- and cytokine stimulation-dependent manner
- DOI:10.4049/jimmunol.174.8.4621
- 发表时间:2005-04-15
- 期刊:
- 影响因子:4.4
- 作者:Toyama-Sorimachi, N;Omatsu, Y;Karasuyama, H
- 通讯作者:Karasuyama, H
Inhibitory NK receptor Ly49Q is expressed on subsets of dendritic cells in a cellular maturation- and cytokine stimulation-dependen manner.
抑制性 NK 受体 Ly49Q 以细胞成熟和细胞因子刺激依赖性方式在树突细胞亚群上表达。
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:Toyama-Sorimachi;N.;Omatsu;Y.;Onoda;A.;Tsujimura;Y.;Iyoda;T.;Kikuchi-Maki;A.;Sorimachi;H.;Dohi;T.;Taki;S.;Inaba;K.;Karasuyama;H.
- 通讯作者:H.
Terauchi, M., et al.: "Placental extravillous cytotrophoblasts persistently express class I major histocom patibility complex molecules after human cytomegalovirus infection."J.Virol.. 77. 8187-8195 (2003)
Terauchi, M., 等人:“人巨细胞病毒感染后,胎盘绒毛外细胞滋养层持续表达 I 类主要组织相容性复合体分子。”J.Virol.. 77. 8187-8195 (2003)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TOYAMA Noriko其他文献
TOYAMA Noriko的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TOYAMA Noriko', 18)}}的其他基金
Vitalistic Causality in Children's Biological Thought
儿童生物思想中的活力因果关系
- 批准号:
22530723 - 财政年份:2010
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of the Vitalistic causality as an cross mind-body explanation framework.
发展生命主义因果关系作为跨心身解释框架。
- 批准号:
19530599 - 财政年份:2007
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Functional analysis of a novel inhibitory receptor expressed on plasmacytoid dendritic cells
浆细胞样树突状细胞表达的新型抑制性受体的功能分析
- 批准号:
17590445 - 财政年份:2005
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Children's awareness of psychosomatic phenomena
儿童对心身现象的认识
- 批准号:
15530435 - 财政年份:2003
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Molecular Control of Plasmacytoid Dendritic Cell Development and Function
浆细胞样树突状细胞发育和功能的分子控制
- 批准号:
10583989 - 财政年份:2023
- 资助金额:
$ 2.3万 - 项目类别:
Application of disease-specific plasmacytoid dendritic cell derived from patient iPS cell to pathological analysis and treatment.
源自患者 iPS 细胞的疾病特异性浆细胞样树突状细胞在病理分析和治疗中的应用。
- 批准号:
21K16305 - 财政年份:2021
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Functional elucidation of plasmacytoid dendritic cell-regulatory T cell linkage regulated by fatty acid binding proteins
脂肪酸结合蛋白调节的浆细胞样树突状细胞-调节性T细胞连接的功能阐明
- 批准号:
20K19632 - 财政年份:2020
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
IgA-containing immune complexes in plasmacytoid dendritic cell activation in SLE
含 IgA 的免疫复合物在 SLE 浆细胞样树突细胞激活中的作用
- 批准号:
10170270 - 财政年份:2020
- 资助金额:
$ 2.3万 - 项目类别:
Unraveling Mechanisms of Plasmacytoid Dendritic Cell Priming by CD169+ Macrophages in Severe Murine Malaria
揭示严重鼠疟疾中 CD169 巨噬细胞引发浆细胞样树突状细胞的机制
- 批准号:
9756511 - 财政年份:2019
- 资助金额:
$ 2.3万 - 项目类别:
Blastic plasmacytoid dendritic cell neoplasm and the related diseases: Development of diagnostic methods and elucidation of pathogenesis
母细胞性浆细胞样树突状细胞肿瘤及相关疾病:诊断方法的发展和发病机制的阐明
- 批准号:
19K16596 - 财政年份:2019
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Characterization of BATF functions in plasmacytoid dendritic cell development and type I interferon production in antiviral immune responses
BATF 在浆细胞样树突状细胞发育和抗病毒免疫反应中 I 型干扰素产生中的功能表征
- 批准号:
414000194 - 财政年份:2019
- 资助金额:
$ 2.3万 - 项目类别:
Research Grants
Novel genetic tools for the analysis of plasmacytoid dendritic cell function in vivo
用于分析体内浆细胞样树突状细胞功能的新型遗传工具
- 批准号:
9975706 - 财政年份:2019
- 资助金额:
$ 2.3万 - 项目类别:
Targeting blastic plasmacytoid dendritic cell neoplasm (BPDCN)
靶向母细胞性浆细胞样树突状细胞肿瘤 (BPDCN)
- 批准号:
10335170 - 财政年份:2018
- 资助金额:
$ 2.3万 - 项目类别:
Targeting blastic plasmacytoid dendritic cell neoplasm (BPDCN)
靶向母细胞性浆细胞样树突状细胞肿瘤 (BPDCN)
- 批准号:
10332257 - 财政年份:2018
- 资助金额:
$ 2.3万 - 项目类别: